The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...
WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...
Pfizer is restarting production in phases, with full production across the site’s three manufacturing suites expected to come back online by the end of the year. (Pfizer) In the aftermath of a ...
Maiva Pharma, a leading global contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) specialising in sterile injectables, inaugurated its new ...
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility ...
Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...
COSTA MESA, CA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO ...
"We're about to open up our manufacturing plant this week, where we will be releasing sterile injectables for generics that are in short supply. We're going to start shipping sterile injectables and ...
Hosted on MSN
Jubilant Pharmova arm to invest $300 mn in US by FY28 to double sterile injectable capacity
Jubilant HollisterStier LLC, an arm of Jubilant Pharmova Ltd, will invest USD 300 million by FY28 in the US to double its sterile injectable manufacturing capacity, with President Donald Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results